Verify any claim · lenz.io
Claim analyzed
Science“Colossal Biosciences is attempting to revive the woolly mammoth through genetic engineering.”
The conclusion
Multiple independent, high-authority sources — including AP News, Chemical & Engineering News, Forbes, and KNKX — confirm that Colossal Biosciences is actively pursuing woolly mammoth de-extinction through CRISPR-based genetic engineering. The company has demonstrated concrete milestones, such as engineering mammoth traits into mice, and has stated plans to edit Asian elephant genomes toward a mammoth-like animal. The claim describes an ongoing attempt, not an achieved result, and is well-supported by the evidence.
Based on 10 sources: 7 supporting, 1 refuting, 2 neutral.
Caveats
- The resulting animal would be a gene-edited Asian elephant hybrid with mammoth-like traits, not a true woolly mammoth clone — the meaning of 'revival' involves taxonomic and definitional nuance.
- The project is scientifically controversial, with independent scientists questioning whether a mammoth-like animal could survive or be sustained in the modern world.
- Colossal's stated 2028 target for mammoth-like elephant calves is widely considered highly speculative by the scientific community.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
The George Church–cofounded de-extinction company, Colossal Laboratories and Biosciences has announced that it has successfully engineered woolly mammoth hair traits into mice... CEO and cofounder Ben Lamm says that Colossal is “the world's first de-extinction and species preservation company” and that creating the woolly mice is one of the first steps toward functionally bringing back the woolly mammoth from extinction. Eventually, the team plans to build on these results to modify the genomes of Asian elephants, the closest living relative of the mammoths, to give them the traits of woolly mammoths.
In an extraordinary achievement of advanced multiplexed genome engineering, Colossal Biosciences announces the birth of the Colossal Woolly Mouse—mice engineered to express multiple key mammoth-like traits that provide adaptations to life in cold climates. This achievement demonstrates the feasibility of expressing traits using information learned from the computational analysis of 59 woolly, Columbian, and steppe mammoth genomes, confirming these pathways as the crucial targets for mammoth de-extinction.
Scientists at the biotech company Colossal Biosciences are trying what they say is the next best thing to restoring ancient beasts — genetically engineering living animals with qualities to resemble extinct species like the woolly mammoth. On Tuesday, Colossal announced that its scientists have simultaneously edited seven genes in mice embryos to create mice with long, thick, woolly hair, nicknamed the "Colossal woolly mouse."
Colossal has the audacious goal of resurrecting extinct species like the woolly mammoth, Tasmanian tiger and dodo bird. Colossal scientists are analyzing dozens of mammoth DNA samples and comparing them to genetic material from living elephants to pinpoint critical genes, using those genetic guideposts to try to create cloned, gene-edited mammoth embryos from the skin cells of Asian elephants.
Such revivals have stirred controversy among some conservationists and biologists, especially in persnickety corners of taxonomic species definition, but also have drawn the interest of investors. Beth Shapiro, a scientist on Colossal's team, stated, "The pace of change is faster than evolution can keep up and if we want to see all of these species alive in the future, we need the technologies that we're developing."
In 2021, the for-profit bioscience company Colossal established ownership of the Woolly Mammoth project. 'We are proud to have helped lay the foundation for the Woolly Mammoth Revival over the past nine years. We look forward to sharing our knowledge and support of this grand vision.'
Colossal Biosciences, founded in 2021 by George Church and Ben Lamm, publicly announced its woolly mammoth de-extinction project using CRISPR-based genetic engineering to edit Asian elephant cells with mammoth traits. The project aims for mammoth-like elephant calves by 2028, with recent milestones including 'woolly mice' in 2025 as a proof-of-concept for gene edits.
Dr. Beth Shapiro and the scientists at Colossal have introduced the Colossal Woolly Mouse, a major milestone in genetic engineering. With seven edited genes, this tiny pioneer exhibits mammoth-like traits, including golden fur and cold resistance. ... Colossal is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth.
As part of their ambitious goal to bring back the woolly mammoth by 2028, Colossal Biosciences has introduced the "Colossal Woolly Mouse." By pinpointing gene families linked to mammoth woolliness, their team used advanced multiplexed genome engineering to target seven genes, creating mice with some of the mammoth’s core phenotypes.
Colossal announced that they had created woolly mice, with the ultimate goal of returning woolly mammoths from extinction. However, critics argue that the world we live in is very different from the world woolly mammoths lived in, and there's no reason to believe our modern-day world would be able to sustain a woolly mammoth population.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
Expert review
How each expert evaluated the evidence and arguments
Expert 1 — The Logic Examiner
The logical chain from evidence to claim is direct and unambiguous: Sources 1 (C&EN), 2 (CRISPR Medicine News), 3 (AP News), 4 (KNKX), 5 (Forbes), 6 (Revive & Restore), and 7 (LLM Background Knowledge) all consistently confirm that Colossal Biosciences has an explicit, ongoing program using CRISPR-based genetic engineering with the stated goal of reviving the woolly mammoth — demonstrated through concrete milestones like the "woolly mouse" and plans to edit Asian elephant genomes. The opponent's argument commits a clear equivocation fallacy by conflating "attempting to revive" with "having already revived," and their appeal to controversy (Sources 4 and 10) is a non sequitur — the feasibility or ethical contestedness of the project does not logically negate that an attempt is actively underway; the claim as worded ("is attempting to revive") is fully and directly supported by the evidence, making it unambiguously true.
Expert 2 — The Context Analyst
The claim states Colossal Biosciences is "attempting to revive the woolly mammoth through genetic engineering" — a statement about ongoing effort and intent, not achieved outcome. All major sources (Sources 1–5, 7) confirm this is precisely what the company is doing: analyzing mammoth genomes, engineering mammoth-like traits into mice as proof-of-concept, and planning to apply edits to Asian elephant cells toward a mammoth-like animal. The missing context worth noting includes: (1) the result would be a gene-edited elephant hybrid, not a true woolly mammoth clone, raising taxonomic and definitional questions; (2) the project is scientifically controversial and faces feasibility challenges (Sources 4, 10); and (3) a 2028 target for mammoth-like calves remains highly speculative. However, none of these omissions undermine the core claim — "attempting to revive" accurately captures the company's stated mission and active research program, and the claim makes no assertion of success or certainty. The framing is fair and the claim holds up fully under scrutiny.
Expert 3 — The Source Auditor
High-authority, independent reporting from Chemical & Engineering News (Source 1) and AP (Source 3), plus a credible public-radio report from KNKX (Source 4), all describe Colossal Biosciences' stated goal and ongoing work as using genetic engineering/gene editing (e.g., mammoth-trait “woolly mice,” planned edits in Asian elephants) as steps toward de-extinction/reconstructing a mammoth-like animal. No comparably reliable source in the pool disputes that Colossal is attempting this; the lone “refute” item (Source 10, a student opinion piece) critiques feasibility/ethics rather than contradicting the company's attempt, so the claim is supported by the best available evidence.
Expert summary
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
Multiple independent reports state that Colossal Biosciences' explicit goal is de-extinction of the woolly mammoth using genetic engineering—demonstrated by engineering “woolly mammoth traits” into mice as a proof-of-concept and described as an early step toward “functionally bringing back the woolly mammoth” (Source 1, Chemical & Engineering News; Source 3, AP News). They further report the company's plan to apply multiplex genome editing to Asian elephants—the mammoth's closest living relative—to introduce mammoth-like traits and ultimately create gene-edited embryos on the path to a revived mammoth (Source 1, Chemical & Engineering News; Source 4, KNKX; Source 2, CRISPR Medicine News).
Your argument commits a glaring equivocation fallacy — you conflate "attempting to revive" with actually reviving, but the claim states Colossal is "attempting to revive the woolly mammoth through genetic engineering," which is precisely what all sources confirm, including Source 1 and Source 4; however, your own cited sources make clear these are only early-stage proof-of-concept milestones on mice, not mammoths, meaning the claim's phrasing dangerously overstates scientific progress by implying a mammoth revival is meaningfully underway. Furthermore, you cherry-pick the aspirational language from Source 1 and Source 2 while ignoring that Source 10 explicitly flags critics who challenge whether a woolly mammoth could even survive in the modern world, and Source 4 acknowledges the project "breeds controversy" — exposing that what Colossal is doing remains a deeply contested, unproven endeavor far removed from any genuine mammoth revival.
Argument against
While Colossal Biosciences has conducted genetic engineering experiments such as creating woolly mice (Source 1, Source 2), these efforts fall critically short of "reviving the woolly mammoth" — they represent preliminary proof-of-concept work on mice and elephants, not an actual mammoth revival, meaning the claim fundamentally misrepresents the scientific reality by conflating aspirational gene-editing milestones with the actual resurrection of an extinct species. Furthermore, Source 10 (The Daily Campus) highlights that critics argue there is no credible basis to believe a woolly mammoth population could even be sustained in the modern world, and Source 4 (KNKX) notes the project "breeds controversy," underscoring that what Colossal is doing is an unproven, contested attempt — not an achieved or even clearly achievable revival of the woolly mammoth.
You're attacking a straw man by treating the claim as “Colossal has already resurrected a mammoth,” when it only says they are attempting revival via genetic engineering—exactly what C&EN reports as a plan to modify Asian elephant genomes as steps toward “functionally bringing back the woolly mammoth” (Source 1, Chemical & Engineering News) and what AP describes as an effort to reconstruct mammoth-like animals through gene edits (Source 3, AP News). Your reliance on “controversy” and habitat-sustainability critiques (Source 4, KNKX; Source 10, The Daily Campus) is a non sequitur: feasibility and ethics debates don't negate that Colossal's stated objective and ongoing gene-editing program constitute an attempt to revive the mammoth (Sources 1–2, 4).